Altimmune
Developing pemvidutide across MASH, AUD, and alcohol-associated liver disease.
$3.12
After-hours close−0.00 (−0.12%)
At close$3.13(−3.55%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.14 | −$0.12 | +11.4% |
| May 2026 | −$0.25 | −$0.18 | +28.0% |
| Mar 2026 | −$0.25 | −$0.27 | −8.0% |
| Nov 2025 | −$0.29 | −$0.21 | +27.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.14 | — | — | $1.8K | — | — |
| Aug 11, 2026 | −$0.14 | −$0.12 | +11.4% | $2.0K | $46.0K | +2,200.0% |
| May 13, 2026 | −$0.25 | −$0.18 | +28.0% | $1.4K | — | — |
| Mar 5, 2026 | −$0.25 | −$0.27 | −8.0% | $556 | $26.0K | +4,576.3% |
| Nov 6, 2025 | −$0.29 | −$0.21 | +27.6% | $560 | $5.0K | +792.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 13, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 11, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 15, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 10, 2021 | ||||||
| May 17, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 11, 2020 | ||||||
| May 13, 2020 | ||||||
| Mar 27, 2020 | ||||||
| Nov 13, 2019 | ||||||
| Aug 13, 2019 | ||||||
| May 14, 2019 | ||||||
| Apr 1, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Aug 14, 2018 | ||||||
| May 15, 2018 | ||||||
| Mar 28, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 3, 2017 | ||||||
| Mar 14, 2017 | ||||||
| Nov 4, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 9, 2016 | ||||||
| Mar 11, 2016 | ||||||
| Nov 6, 2015 | ||||||
| Aug 5, 2015 | ||||||